Organigram Global Inc.
OGINasdaqCIK 1620737HealthcareFiscal year ends Sep 30
Revenue is not reported in this company’s XBRL financial statements.
Latest quarter: not reported
Last eight quarters
Full statements| Line item | Unit | Shape over the periods |
|---|---|---|
| Revenue | $ | |
| Gross margin | % | |
| Operating margin | % | |
| Net margin | % | |
| Diluted EPS | $ per share | |
| Free cash flow | $ |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20192019-08-31 | FY20202020-08-31 | FY20212021-08-31 | FY20222022-08-31 | FY20242024-09-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $m | 80.4Revenue, FY2019, twelve months to 2019-08-31CAD 80.4m. XBRL concept ifrs-full:Revenue. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | 86.8Revenue, FY2020, twelve months to 2020-08-31CAD 86.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | 79.2Revenue, FY2021, twelve months to 2021-08-31CAD 79.2m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | 146Revenue, FY2022, twelve months to 2022-08-31CAD 145.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | 160Revenue, FY2024, twelve months to 2024-09-30CAD 159.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure | |
| Gross margin | % | 60.3%Gross margin, FY2019, twelve months to 2019-08-31. gross profit / revenueGross profit: CAD 48.5m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2020-11-30, accession 0001062993-20-005949.Revenue: CAD 80.4m. XBRL concept ifrs-full:Revenue. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | (65.1%)Gross margin, FY2020, twelve months to 2020-08-31. gross profit / revenueGross profit: −CAD 56.5m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2021-11-23, accession 0001062993-21-011478.Revenue: CAD 86.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | (35.9%)Gross margin, FY2021, twelve months to 2021-08-31. gross profit / revenueGross profit: −CAD 28.4m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2022-11-29, accession 0001628280-22-030921.Revenue: CAD 79.2m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | 21.7%Gross margin, FY2022, twelve months to 2022-08-31. gross profit / revenueGross profit: CAD 31.6m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2023-12-19, accession 0001628280-23-041900.Revenue: CAD 145.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | 29.7%Gross margin, FY2024, twelve months to 2024-09-30. gross profit / revenueGross profit: CAD 47.5m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2024-12-18, accession 0001628280-24-051826.Revenue: CAD 159.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure | |
| Operating margin | % | 6.8%Operating margin, FY2019, twelve months to 2019-08-31. operating income / revenueOperating income: CAD 5.5m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2020-11-30, accession 0001062993-20-005949.Revenue: CAD 80.4m. XBRL concept ifrs-full:Revenue. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | (167.6%)Operating margin, FY2020, twelve months to 2020-08-31. operating income / revenueOperating income: −CAD 145.5m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2021-11-23, accession 0001062993-21-011478.Revenue: CAD 86.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | (116.0%)Operating margin, FY2021, twelve months to 2021-08-31. operating income / revenueOperating income: −CAD 91.8m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2022-11-29, accession 0001628280-22-030921.Revenue: CAD 79.2m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | (29.6%)Operating margin, FY2022, twelve months to 2022-08-31. operating income / revenueOperating income: −CAD 43.2m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2023-12-19, accession 0001628280-23-041900.Revenue: CAD 145.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | (22.3%)Operating margin, FY2024, twelve months to 2024-09-30. operating income / revenueOperating income: −CAD 35.7m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2024-12-18, accession 0001628280-24-051826.Revenue: CAD 159.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure | |
| Net margin | % | (11.9%)Net margin, FY2019, twelve months to 2019-08-31. net income / revenueNet income: −CAD 9.5m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2020-11-30, accession 0001062993-20-005949.Revenue: CAD 80.4m. XBRL concept ifrs-full:Revenue. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | (156.9%)Net margin, FY2020, twelve months to 2020-08-31. net income / revenueNet income: −CAD 136.2m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2021-11-23, accession 0001062993-21-011478.Revenue: CAD 86.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | (165.1%)Net margin, FY2021, twelve months to 2021-08-31. net income / revenueNet income: −CAD 130.7m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2022-11-29, accession 0001628280-22-030921.Revenue: CAD 79.2m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | (9.8%)Net margin, FY2022, twelve months to 2022-08-31. net income / revenueNet income: −CAD 14.3m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2023-12-19, accession 0001628280-23-041900.Revenue: CAD 145.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | (28.4%)Net margin, FY2024, twelve months to 2024-09-30. net income / revenueNet income: −CAD 45.4m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2024-12-18, accession 0001628280-24-051826.Revenue: CAD 159.8m. XBRL concept ifrs-full:Revenue. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure | |
| Diluted EPS | $ per share | (0.07)Diluted EPS, FY2019, twelve months to 2019-08-31−CAD 0.07 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | (0.79)Diluted EPS, FY2020, twelve months to 2020-08-31−CAD 0.79 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | (0.51)Diluted EPS, FY2021, twelve months to 2021-08-31−CAD 0.51 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | (0.18)Diluted EPS, FY2022, twelve months to 2022-08-31−CAD 0.18 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | (0.48)Diluted EPS, FY2024, twelve months to 2024-09-30−CAD 0.48 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure | |
| Free cash flow | $m | (144)Free cash flow, FY2019, twelve months to 2019-08-31. operating cash flow − capital expenditureOperating cash flow: −CAD 35.1m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2020-11-30, accession 0001062993-20-005949.Capital expenditure: CAD 108.8m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2020-11-30, accession 0001062993-20-005949.Report this figure | (122)Free cash flow, FY2020, twelve months to 2020-08-31. operating cash flow − capital expenditureOperating cash flow: −CAD 45.1m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2021-11-23, accession 0001062993-21-011478.Capital expenditure: CAD 77.2m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2021-11-23, accession 0001062993-21-011478.Report this figure | (40.3)Free cash flow, FY2021, twelve months to 2021-08-31. operating cash flow − capital expenditureOperating cash flow: −CAD 28.6m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2022-11-29, accession 0001628280-22-030921.Capital expenditure: CAD 11.8m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2022-11-29, accession 0001628280-22-030921.Report this figure | (85.0)Free cash flow, FY2022, twelve months to 2022-08-31. operating cash flow − capital expenditureOperating cash flow: −CAD 36.2m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2023-12-19, accession 0001628280-23-041900.Capital expenditure: CAD 48.7m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2023-12-19, accession 0001628280-23-041900.Report this figure | (0.9)Free cash flow, FY2024, twelve months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: CAD 3.9m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2024-12-18, accession 0001628280-24-051826.Capital expenditure: CAD 4.7m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2024-12-18, accession 0001628280-24-051826.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Tidal Investments LLC | 2026-06-30 | $2.2m | 2,164,878 | Reduced−3,519 | |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $1.5m | 1,444,148 | Reduced−195,900 | |
| AdvisorShares Investments LLC | 2026-06-30 | $905.8k | 888,057 | Reduced−59,383 | |
| GOLDMAN SACHS GROUP INC | 2026-06-30 | $623.7k | 611,479 | Added+40,110 | |
| MORGAN STANLEY | 2026-06-30 | $314.3k | 308,108 | Reduced−56,076 | |
| Baader Bank Aktiengesellschaft | 2026-06-30 | $254.5k | 250,000 | Reduced−12,980 | |
| BANK OF MONTREAL /CAN/ | 2026-06-30 | $243.5k | 238,434 | Added+380 | |
| Formidable Asset Management, LLC | 2026-06-30 | $214.8k | 160,311 | Added+3,562 | |
| UBS Group AG | 2026-06-30 | $212.9k | 208,770 | Added+176,155 | |
| Leonteq Securities AG | 2026-06-30 | $180.4k | 124,849 | Reduced−13,662 |
Recent filings
All 320 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1515:32 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-15 | 0001628280-26-065965 |
| 2026-09-3019:26 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-30 | 0001628280-26-063957 |
| 2026-09-0310:53 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-30 | 0001628280-26-060243 |
| 2026-09-0101:02 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-18 | 0001062993-26-004753 |
| 2026-08-2017:53 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-20 | 0001628280-26-058209 |
| 2026-08-1111:33 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-30 | 0001628280-26-055496 |
| 2026-08-0414:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-04 | 0001628280-26-052218 |
| 2026-07-2020:53 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-20 | 0001628280-26-048830 |
| 2026-05-1211:43 ET | 6-K | Report of a foreign private issuerPeriod 2026-03-31 | 0001628280-26-033882 |
| 2026-05-0619:28 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-06 | 0001628280-26-031177 |
Latest annual report
Form 40-F for the fiscal year ended Sep 30, 2025Filed Dec 16, 2025. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 1620737
- Tickers
- OGI
- Exchange
- Nasdaq
- SIC code
- 2834 Pharmaceutical Preparations
- Sector
- Healthcare
- Fiscal year ends
- Sep 30
- Incorporated in
- Z4
- Filer category
- <br>Emerging growth company
- Former names
- ORGANIGRAM HOLDINGS INC. (to 2025-04-01); ORGANIGRAM HOLDINGS INC (to 2016-07-21)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.